Cyclosporine-A increases locomotor activity in rats with 6- hydroxydopamine-induced hemiparkinsonism: Relevance to neural transplantation

Surgical Neurology

Volumn 46, Issue 4, 1996, Pages 384-388

  Borlongan, Cesario V ^a   Freeman, Thomas B ^a   Hauser, Robert A ^a   Cahill, David W ^a   Sanberg, Paul R ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

6 hydroxydopamine; amphetamine; Cyclosporine A; immunosuppression; motor assymmetry; Parkinson's disease

Indexed keywords

CYCLOSPORIN A; DEXAMPHETAMINE; IMMUNOSUPPRESSIVE AGENT; OLIVE OIL; OXIDOPAMINE;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY EQUILIBRIUM; CIRCLING BEHAVIOR; CONTROLLED STUDY; IMMUNOSUPPRESSIVE TREATMENT; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MOTOR ACTIVITY; NERVE TRANSPLANTATION; NONHUMAN; PARKINSONISM; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030272984     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-3019(96)00190-5     Document Type: Article

References (25)

1. 1. Barker CF, Billingham RE. Immunologically privileged sites. Adv Immunol 1977;25:1-54.
2. 2. Borlongan CV, Freeman TB, Scorcia T, Sherman K, Olanow CW, Cahill DW, Sanberg PR. Cyclosporine-A increases spontaneous and dopamine-agonist locomotor activity. Cell Transplant 1995;1:65-73.
3. 3. Borlongan CV, Randall TS, Cahill DW, Sanberg PR. Asymmetrical motor behavior in rats with striatal lesions as revealed by the elevated body swing test. Brain Res 1995;676:231-4.
4. 4. Borlongan CV, Sanberg PR. Elevated body swing test: a new behavioral parameter for rats with 6-hydroxydopamine-induced hemiparkinsonism. J Neurosci 1995;15:5372-8.
5. 5. Brundin P, Nilsson OG, Gage FH, Bjorklund A. Cyclosporine-A increases survival of cross-species intrastriatal grafts of embryonic dopamine-containing neurons. Exp Brain Res 1985;60:204-8.
6. 6. Brundin P, Strecker RE, Widner H, Clarke DJ, Nilsson OG, Åstedt B, Lindvall O, Björklund A. Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: immunological aspects, spontaneous and drug-induced behaviour, and dopamine release. Exp Brain Res 1988;70:192-208.
7. 7. Calne RY, Rolles K, White DJG, Thiru S, Evans DB, McMaster P, Dunn DB, Craddock GN, Henderson RG, Aziz S, Lewis P. Cyclosporine-A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreas and 2 livers. Lancet 1979;2:1033-6.
8. 8. Famiglio L, Racusen L, Fivush B, Solez K, Fisher R. Central nervous system toxicity of cyclosporine in a rat model. Transplantation 1989;48:316-21.
9. 9. Finsen BR, Sorensen T, Gonzalez B, Castellano B, Zimmer J. Immunological reactions to neural grafts in the central nervous system. Restor Neurol Neurosci 1991;2:271-82.
10. 10. Freeman TB, Brandies L, Pearson J, Flamm ES. Cross-species grafts of embryonic rabbit mesencephalic tissue survives and causes behavioral recovery in the presence of chronic immunosuppression. Ann NY Acad Sci 1987;495:699-702.
11. 11. Freire-Garabal M, Nunez MJ, Balboa JL, Gonalez-Bahillo J, Belmonte A. Effects of midazolam on the activity on T-cell immunosuppressive response to surgical stress in mice. Pharmacol Biochem Behav 1992;43:85-9.
12. 12. Hudson JL, Hoffman A, Stromberg I, Hoffer BJ, Moorhead JW. Allogeneic grafts of fetal dopamine neurons: behavioral indices of immunological interactions. Neurosci Lett 1994;171:32-6.
13. 13. Klug JM, Norman AB. Long-term sensitization of apomorphine-induced rotation behavior in rats with dopamine deafferentation or excitotoxin lesions of the striatum. Pharmacol Biochem Behav 1993;46:397-403.
14. 14. Law PK, Goodwin TG, Quiwen F, Vijaya D, Larkin C, Florendo JA, Kirby DS, Deering MB, Li HJ, Chen M, Yoo TJ, Cornett J, Li LM, Shirzad A, Quinley T, Holcomb R. Feasibility, safety, and efficacy of myoblast transfer on Duchenne muscular dystrophy boys. Cell Transplant 1992;1:235-44.
15. 15. Lindvall O, Rehncrona S, Brundin P, Gustavii B, Astedt B, Widner H, Lindholm T, Bjorklund A, Leenders KL, Rothwell JC, Frackowiak R, Mardsen CD, Johnels B, Steg G, Freedman R, Hoffer BJ, Seiger A, Bygdeman M, Stromberg I, Olsen L. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease: a detailed account of methodology and a 6-month follow-up. Arch Neurol 1989; 46:615-31.
16. 16. Medawar PB. Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol 1948;29:58-69.
17. 17. Norman AB, Wyatt LM, Hildebrand JP, Kolmonpunporn M, Moody CA, Lehman MN, Sanberg PR. Sensitization of rotation behavior in rats with unilateral 6-hydroxydopamine or kainic acid-induced striatal lesions. Pharmacol Biochem Behav 1990;37:755-9.
18. 18. Okimura T, Ogawa M, Yamauchi T. Stress and immune response III: effect of restraint stress on delayed type hypersensitivity (DTH) response, natural killer (NK) activity and phagocytosis in mice. Jpn J Pharmacol 1986;41:229-35.
19. 19. Powles RL, Clink HM, Spence D, Morgenstern G, Watson JG, Shelby PJ, Woods M, Barrett A, Jameson B, Sloane J, Lawler SD, Kay HEM, Lawson D, McElwain TJ, Alexander P. Cyclosporine-A to prevent GVHD in man after allogenic bone-marrow transplantation. Lancet 1980;1:327-9.
20. 20. Sanberg PR, Wictorin K, Isacson O. Cell transplantation for Huntington's Disease. Boca Raton, Florida: CRC Press, 1994:1-124.
21. 21. Scheinberg LC, Edelman FL, Levy AW. Is the brain an immunologically privileged site? Arch Neurol 1964;11:248-64.
22. 22. Shanks N, Renton C, Zalcman S, Anisman H. Influence of change from grouped to individual housing on a T-cell-dependent immune response in mice: antagonism by diazepam. Pharmacol Biochem Behav 1993;47:497-502.
23. 23. Sloan DJ, Wood MJ, Charlton HM. The immune response to intracerebral neural grafts. Trends Neurosci 1991;14:341-6.
24. 24. Widner H, Brundin P. Immunological aspects of grafting in the mammalian central nervous system: a review and speculative synthesis. Brain Res Rev 1988;13:287-324.
25. 25. Widner H, Brundin P, Bjorklund A, Moller E. Survival and immunogenicity of dissociated allogeneic fetal neural dopamine-rich grafts when implanted into the brains of adult mice. Exp Brain Res 1989;76:187-97.